Innovation Theater at ACR Convergence 2026
- Cabaletta will present an oral presentation (0902) on one-year clinical responses in dermatomyositis patients treated with rese-cel at 1:00 p.m. ET on Sunday, November 8, and three poster presentations (1222, 1673, 1728) on updated rese-cel clinical and safety data and the opportunity of CAR T cell therapy in autoimmune diseases from 10:30 a.m. – 12:30 p.m. ET on Monday, November 9.
- Cabaletta will host an industry-supported Innovation Theater titled, “Designed for Autoimmunity: Rese-cel and the RESET™ Clinical Program,” featuring David J. Chang, M.D., M.P.H., FACR, Chief Medical Officer of Cabaletta Bio, David L. Porter, M.D., Jodi Fisher Horowitz Professor of Leukemia Care Excellence and Director, Center for Cell Therapy and Transplant, University of Pennsylvania, and Dinesh Khanna, M.D., M.Sc., FACR, Frederick G. L. Huetwell Professor of Medicine and Director, University of Michigan Scleroderma Program, at 1:30 p.m. ET on Tuesday, November 10.